Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2010-3-19
pubmed:abstractText
UCP2 -866G>A (rs659366) has been implicated in cardiometabolic disease and represents a novel candidate gene for beta-blocker response, particularly among patients with diabetes. We assessed the function of -866G>A and its role as a modifier of beta-blocker treatment outcomes by diabetes status in an acute coronary syndrome (ACS) cohort.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/20145583-10412986, http://linkedlifedata.com/resource/pubmed/commentcorrection/20145583-10825195, http://linkedlifedata.com/resource/pubmed/commentcorrection/20145583-11311236, http://linkedlifedata.com/resource/pubmed/commentcorrection/20145583-11381268, http://linkedlifedata.com/resource/pubmed/commentcorrection/20145583-11433333, http://linkedlifedata.com/resource/pubmed/commentcorrection/20145583-12401727, http://linkedlifedata.com/resource/pubmed/commentcorrection/20145583-12915397, http://linkedlifedata.com/resource/pubmed/commentcorrection/20145583-14623810, http://linkedlifedata.com/resource/pubmed/commentcorrection/20145583-14747301, http://linkedlifedata.com/resource/pubmed/commentcorrection/20145583-15039126, http://linkedlifedata.com/resource/pubmed/commentcorrection/20145583-15113779, http://linkedlifedata.com/resource/pubmed/commentcorrection/20145583-15448158, http://linkedlifedata.com/resource/pubmed/commentcorrection/20145583-15604415, http://linkedlifedata.com/resource/pubmed/commentcorrection/20145583-16189366, http://linkedlifedata.com/resource/pubmed/commentcorrection/20145583-16331092, http://linkedlifedata.com/resource/pubmed/commentcorrection/20145583-16580698, http://linkedlifedata.com/resource/pubmed/commentcorrection/20145583-16644712, http://linkedlifedata.com/resource/pubmed/commentcorrection/20145583-16766516, http://linkedlifedata.com/resource/pubmed/commentcorrection/20145583-17289742, http://linkedlifedata.com/resource/pubmed/commentcorrection/20145583-18192542, http://linkedlifedata.com/resource/pubmed/commentcorrection/20145583-18433713, http://linkedlifedata.com/resource/pubmed/commentcorrection/20145583-19208352, http://linkedlifedata.com/resource/pubmed/commentcorrection/20145583-19706383, http://linkedlifedata.com/resource/pubmed/commentcorrection/20145583-2752565
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
1744-6880
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
20
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
231-8
pubmed:dateRevised
2011-7-27
pubmed:meshHeading
pubmed-meshheading:20145583-Acute Coronary Syndrome, pubmed-meshheading:20145583-Adrenergic beta-Antagonists, pubmed-meshheading:20145583-Aged, pubmed-meshheading:20145583-Cell Line, pubmed-meshheading:20145583-Cohort Studies, pubmed-meshheading:20145583-Diabetes Complications, pubmed-meshheading:20145583-Diabetes Mellitus, pubmed-meshheading:20145583-Female, pubmed-meshheading:20145583-Gene Expression, pubmed-meshheading:20145583-Genetic Association Studies, pubmed-meshheading:20145583-Humans, pubmed-meshheading:20145583-Ion Channels, pubmed-meshheading:20145583-Male, pubmed-meshheading:20145583-Middle Aged, pubmed-meshheading:20145583-Mitochondrial Proteins, pubmed-meshheading:20145583-Obesity, pubmed-meshheading:20145583-Pharmacogenetics, pubmed-meshheading:20145583-Polymorphism, Single Nucleotide, pubmed-meshheading:20145583-Recombinant Proteins, pubmed-meshheading:20145583-Transcription, Genetic, pubmed-meshheading:20145583-Transfection
pubmed:year
2010
pubmed:articleTitle
Interaction between the UCP2 -866 G>A polymorphism, diabetes, and beta-blocker use among patients with acute coronary syndromes.
pubmed:affiliation
Endocrinology, Diabetes and Nutrition Division, University of Maryland School of Medicine, 660 W. Redwood Street, Baltimore, MD 21201, USA. abeitels@medicine.umaryland.edu
pubmed:publicationType
Journal Article, Research Support, N.I.H., Extramural